Skip to main content
R

Rapidemic

Rapidemic provides a cartridge‑based molecular test for chlamydia and gonorrhea that delivers laboratory‑grade results in under 30 minutes at the point of care or at home. The single‑step, battery‑operated device integrates sample preparation, nucleic‑acid amplification and automated interpretation, with secure cloud connectivity for immediate result delivery to patients, clinicians and public‑health systems.

Leiden, NetherlandsFounded 2021122K+ followers
Updated 2 months ago

Funding

$3.2M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

BM
Funding rounds are not available yet.

Founders

Product

Problem

Current sexually transmitted infection (STI) diagnostics are either slow and laboratory‑based or rapid but unreliable, limiting timely treatment for patients and hindering public‑health monitoring.

Solution

Rapidemic offers a rapid molecular test for chlamydia and gonorrhea that combines laboratory‑grade accuracy with a fast, user‑friendly workflow. The assay delivers results at the point of care or at home within minutes, eliminating the need for centralized lab processing. Integrated sample preparation and nucleic‑acid amplification enable a single‑step, cartridge‑based test that can be performed by clinicians or individuals without specialized training. Results are securely transmitted to a digital platform, allowing immediate clinical decision‑making and streamlined reporting for public‑health surveillance.

Target Audience

Primary customers are private clinics, healthcare practitioners, and individuals seeking confidential, rapid at‑home STI testing.

Features

  • Cartridge‑based nucleic‑acid amplification test (NAAT) delivering results in under 30 minutes
  • Sample‑to‑answer workflow requiring no separate extraction or equipment setup
  • Portable, battery‑operated device suitable for clinic use or at‑home testing
  • Built‑in quality controls and automated result interpretation to ensure reliability
  • Secure cloud connectivity for instant result delivery to patients, providers, and health authorities
  • Compatible with standard electronic health‑record (EHR) interfaces for seamless data integration
This profile is AI-generated and may contain inaccuracies.